| Patent | Date |
|---|
Thiosemicarbazates And Uses Thereof
App 20220306577 - Al-Abed; Yousef ; et al. | 2022-09-29 |
Thiosemicarbazates and uses thereof
Grant 11,440,881 - Al-Abed , et al. September 13, 2 | 2022-09-13 |
Compounds for use in synthesis of peptidomimetics
Grant 11,414,405 - Al-Abed , et al. August 16, 2 | 2022-08-16 |
Muscarinic Acetylcholine Receptor Subtype 4 Antagonists In The Treatment Of Anemia
App 20220185821 - AL ABED; Yousef ; et al. | 2022-06-16 |
Compounds For Use In Synthesis Of Peptidomimetics
App 20210130331 - Al-Abed; Yousef ; et al. | 2021-05-06 |
Treatment Of Hmgb1-mediated Inflammation
App 20210052690 - Tracey; Kevin J. ; et al. | 2021-02-25 |
Compounds for use in synthesis of peptidomimetics
Grant 10,919,882 - Al-Abed , et al. February 16, 2 | 2021-02-16 |
Hmgb1 Antagonist Treatment Of Severe Sepsis
App 20210000908 - Al-Abed; Yousef | 2021-01-07 |
Treatment of HMGB1-mediated inflammation
Grant 10,857,197 - Tracey , et al. December 8, 2 | 2020-12-08 |
Hmgb1 Antagonist Treatment Of Diabetic Peripheral Neuropathy
App 20200353037 - Al-Abed; Yousef ; et al. | 2020-11-12 |
Peptidomimetic Agents, Synthesis And Uses Thereof
App 20200354404 - Al-Abed; Yousef | 2020-11-12 |
Hmgb1 Antagonist
App 20200352887 - Al-Abed; Yousef ; et al. | 2020-11-12 |
Thiosemicarbazates And Uses Thereof
App 20200354318 - Al-Abed; Yousef ; et al. | 2020-11-12 |
Hmgb1 Antagonist Treatment Of Acute Lung Injury
App 20200354418 - Al-Abed; Yousef | 2020-11-12 |
Compounds For Use In Synthesis Of Peptidomimetics
App 20200354344 - Al-Abed; Yousef ; et al. | 2020-11-12 |
Treatment Method, Compounds, And Method Of Increasing Trpv2 Activity
App 20200277246 - GULKO; Percio S. ; et al. | 2020-09-03 |
Iguratimod As An Mif Inhibitor
App 20190262307 - Al-Abed; Yousef ; et al. | 2019-08-29 |
Treatment Of Hmgb1-mediated Inflammation
App 20180353564 - Tracey; Kevin J. ; et al. | 2018-12-13 |
Treatment of solid tumors by inhibiting MRK/ZAK
Grant 10,144,723 - Ruggieri , et al. De | 2018-12-04 |
Inhibitors Of Abeta And Synuclein Aggregation
App 20180098950 - Al-Abed; Yousef | 2018-04-12 |
Treatment Method, Compounds, And Method Of Increasing Trpv2 Activity
App 20180037528 - GULKO; Percio S. ; et al. | 2018-02-08 |
Treatment Of Solid Tumors By Inhibiting Mrk/zak
App 20170217929 - Ruggieri; Rosamaria ; et al. | 2017-08-03 |
Inhibition of macrophage migration inhibitory factor in melanoma and colon cancer
Grant 9,567,306 - Al-Abed February 14, 2 | 2017-02-14 |
Ephedra Alata Extracts And Methods Of Use Thereof
App 20160296574 - Murad; Osama Mansour ; et al. | 2016-10-13 |
Method for treating a neurological disorder associated with hypoxia using a small moleucule MIF inhibitor
Grant 9,457,013 - Miller , et al. October 4, 2 | 2016-10-04 |
Method for treating glioblastomas and other tumors
Grant 9,440,914 - Al-Abed , et al. September 13, 2 | 2016-09-13 |
Inhibition Of Macrophage Migration Inhibitory Factor In Melanoma And Colon Cancer
App 20150361058 - Al-Abed; Yousef | 2015-12-17 |
Compounds and methods for treatment of systemic lupus erythematosus
Grant 9,096,576 - Al-Abed , et al. August 4, 2 | 2015-08-04 |
Method For Treating Glioblastomas And Other Tumors
App 20140323576 - Al-Abed; Yousef ; et al. | 2014-10-30 |
Compounds And Methods For Treatment Of Systemic Lupus Erythematosus
App 20140309255 - Al-Abed; Yousef ; et al. | 2014-10-16 |
Method For Treating Pathologies Associated With Hypoxia Using Mif Inhibitors
App 20140242091 - Miller; Edmund ; et al. | 2014-08-28 |
Isoxazole and isothiazole compounds useful in the treatment of inflammation
Grant 8,759,376 - Al-Abed , et al. June 24, 2 | 2014-06-24 |
Compounds and methods for treatment of systemic lupus erythematosus
Grant 8,741,924 - Al-Abed , et al. June 3, 2 | 2014-06-03 |
Phenolic hydrazone macrophage migration inhibitory factor inhibitors
Grant 8,742,173 - Al-Abed June 3, 2 | 2014-06-03 |
Method for treating pathologies associated with hypoxia using MIF inhibitors
Grant 8,741,299 - Miller , et al. June 3, 2 | 2014-06-03 |
Modified macrophage migration inhibitory factor inhibitors
Grant 8,618,147 - Al-Abed December 31, 2 | 2013-12-31 |
Methods For Treating Systemic Lupus Erythematosus Using Hiv Protease Inhibitors
App 20130317040 - Al-Abed; Yousef ; et al. | 2013-11-28 |
Antitumor properties of NO modified protease inhibitors
Grant 8,563,578 - Nicoletti , et al. October 22, 2 | 2013-10-22 |
Isoxazoline compounds having MIF antagonist activity
Grant 8,552,040 - Al-Abed October 8, 2 | 2013-10-08 |
Modified Macrophage Migration Inhibitory Factor Inhibitors
App 20130190369 - Al-Abed; Yousef | 2013-07-25 |
Compounds And Methods For Treatment Of Systemic Lupus Erythematosus
App 20130123299 - Al-Abed; Yousef ; et al. | 2013-05-16 |
Modified macrophage migration inhibitory factor inhibitors
Grant 8,362,053 - Al-Abed January 29, 2 | 2013-01-29 |
Method For Treating Pathologies Associated With Hypoxia Using Mif Inhibitors
App 20130004506 - Miller; Edmund ; et al. | 2013-01-03 |
Phenolic Hydrazone Macrophage Migration Inhibitory Factor Inhibitors
App 20120178805 - Al-Abed; Yousef | 2012-07-12 |
(S,R)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent
Grant 8,207,206 - Nicoletti , et al. June 26, 2 | 2012-06-26 |
Phenolic hydrazone macrophage migration inhibitory factor inhibitors
Grant 8,193,247 - Al-Abed June 5, 2 | 2012-06-05 |
Isoxazoline Compounds Having MIF Antagonist Activity
App 20120046325 - AL-ABED; Yousef | 2012-02-23 |
Inhibitors of ASS and Synuclein Aggregation
App 20110201686 - Al-Abed; Yousef | 2011-08-18 |
Antitumor Properties Of No Modified Protease Inhibitors
App 20110195939 - Nicoletti; Ferdinando ; et al. | 2011-08-11 |
Treatment Of Sepsis And Inhibition Of Mif By D-t4
App 20110136911 - Al-Abed; Yousef | 2011-06-09 |
Isoxazoline compounds having MIF antagonist activity
Grant 7,928,130 - Al-Abed April 19, 2 | 2011-04-19 |
Isoxazole And Isothiazole Compounds Useful In The Treatment Of Inflammation
App 20110015231 - Al-Abed; Yousef ; et al. | 2011-01-20 |
(s,r.)-3-phenyl-4,5 Dihydro-5-isoxazole Acetic Acid-nitric Oxide And Use Thereof As Anti-cancer And Antiviral Agent
App 20100305176 - Nicoletti; Ferdinando ; et al. | 2010-12-02 |
Isoxazole and isothiazole compounds useful in the treatment of inflammation
Grant 7,807,696 - Al-Abed , et al. October 5, 2 | 2010-10-05 |
Isoxazoline compounds having MIF antagonist activity
Grant 7,662,843 - Al-Abed February 16, 2 | 2010-02-16 |
Isoxazoline Compounds Having MIF Antagonist Activity
App 20100016391 - Al-Abed; Yousef | 2010-01-21 |
Oxime Derivatives as Inhibitors of Macrophage Migration Inhibitory Factor
App 20090318509 - Al-Abed; Yousef | 2009-12-24 |
Phenolic Hydrazone Macrophage Migration Inhibitory Factor Inhibitors
App 20090170951 - Al-Abed; Yousef | 2009-07-02 |
Modified Macrophage Migration Inhibitory Factor Inhibitors
App 20090137647 - Al-Abed; Yousef | 2009-05-28 |
Isoxazoline compounds having MIF antagonist activity
Grant 7,491,740 - Al-Abed February 17, 2 | 2009-02-17 |
Treatment Of Type 1 Diabetes With Inhibitors Of Macrophage Migration Inhibitory Factor
App 20080305118 - Al-Abed; Yousef | 2008-12-11 |
Anti-inflammatory compounds
App 20070021465 - Al-Abed; Yousef ; et al. | 2007-01-25 |
Isoxazoline compounds having MIF antagonist activity
App 20040204464 - Al-Abed, Yousef | 2004-10-14 |
Compounds having MIF antagonist activity
Grant 6,599,938 - Al-Abed , et al. July 29, 2 | 2003-07-29 |
Isoxazoline compounds having MIF antagonist activity
App 20030008908 - Al-Abed, Yousef | 2003-01-09 |
Compounds and compositions for treating tissue ischemia
App 20020193412 - Tracey, Kevin J. ; et al. | 2002-12-19 |
Immunological advanced glycation endproduct crosslink
Grant 6,380,165 - Al-Abed , et al. April 30, 2 | 2002-04-30 |
Immunological Advanced Glycation Endproduct Crosslink
App 20020022234 - AL-ABED, YOUSEF ; et al. | 2002-02-21 |
| 